Access Bio Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
79
- Stock Symbol
-
950130
- Investments
-
5
- Share Price
-
$1.21
- (As of Tuesday Closing)
Access Bio General Information
Description
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.
Contact Information
Website
www.accessbio.netCorporate Office
- 7 Fitzgerald Avenue
- Monroe Township, NJ 08831
- United States
Corporate Office
- 7 Fitzgerald Avenue
- Monroe Township, NJ 08831
- United States
Access Bio Stock Performance
As of 17-Nov-2026, Access Bio’s stock price is $1.21. Its current market cap is $42.5M with 35.2M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.21 | $1.23 | $1.20 - $3.18 | $42.5M | 35.2M | 124K | -$2.17 |
Access Bio Financials Summary
As of 30-Jun-2026, Access Bio has a trailing 12-month revenue of $16.2M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | (162,689) | (151,061) | (77,538) | (33,458) |
| Revenue | 16,219 | 21,962 | 82,424 | 266,659 |
| EBITDA | (94,467) | (69,410) | 6,458 | (490) |
| Net Income | (76,425) | (57,702) | (255) | (2,427) |
| Total Assets | 409,138 | 422,178 | 502,964 | 536,314 |
| Total Debt | 47,462 | 29,753 | 44,807 | 56,757 |
Access Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Access Bio Comparisons
Industry
Financing
Details
Access Bio Competitors (7)
One of Access Bio’s 7 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories | Corporation | Hercules, CA | ||||
| Trinity Biotech | Corporation | Wicklow, Ireland | ||||
| altona Diagnostics | Corporation | Hamburg, Germany | ||||
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| Orasure Technologies | Corporate Backed or Acquired | Bethlehem, PA |
Access Bio Patents
Access Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250116668-A1 | Multiplexed diagnostic assay device | Pending | 25-Aug-2023 | ||
| WO-2025049225-A2 | Multiplexed diagnostic assay device | Inactive | 25-Aug-2023 | ||
| WO-2025049225-A3 | Multiplexed diagnostic assay device | Inactive | 25-Aug-2023 | ||
| US-12055544-B2 | Diagnostic assay device having microreactor | Active | 25-Aug-2022 | ||
| US-12613242-B2 | Diagnostic assay device having microreactor | Active | 25-Aug-2022 | G01N33/54391 |
Access Bio Signals
Access Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Access Bio Investments & Acquisitions (5)
Access Bio’s most recent deal was a Merger/Acquisition with RF Bio for . The deal was made on 19-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RF Bio | 19-Jan-2026 | Merger/Acquisition | Biotechnology | ||
| AACG | 07-Jan-2026 | Joint Venture | Clinics/Outpatient Services | ||
| CuraPatient | 12-Sep-2023 | Corporate | Clinics/Outpatient Services | ||
| Beright Investment | 26-May-2023 | Merger/Acquisition | Consulting Services (B2B) | ||
| Genecast | 23-Feb-2023 | Later Stage VC | Diagnostic Equipment |
Access Bio Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| RF Bio | Wonju-si, South Korea | 2020 |
Access Bio FAQs
-
When was Access Bio founded?
Access Bio was founded in 2002.
-
Where is Access Bio headquartered?
Access Bio is headquartered in Monroe Township, NJ.
-
What is the size of Access Bio?
Access Bio has 79 total employees.
-
What industry is Access Bio in?
Access Bio’s primary industry is Diagnostic Equipment.
-
Is Access Bio a private or public company?
Access Bio is a Public company.
-
What is Access Bio’s stock symbol?
The ticker symbol for Access Bio is 950130.
-
What is the current stock price of Access Bio?
As of 17-Nov-2026 the stock price of Access Bio is $1.21.
-
What is the current market cap of Access Bio?
The current market capitalization of Access Bio is $42.5M.
-
What is Access Bio’s current revenue?
The trailing twelve month revenue for Access Bio is $16.2M.
-
Who are Access Bio’s competitors?
Bio-Rad Laboratories, Trinity Biotech, altona Diagnostics, Charles River Laboratories International, and Orasure Technologies are some of the 7 competitors of Access Bio.
-
What is Access Bio’s annual earnings per share (EPS)?
Access Bio’s EPS for 12 months was -$2.17.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process